DOI
10.1016/j.jds.2025.07.016
First Page
2472
Last Page
2478
Abstract
Abstract Genomic and mutational sequencing in malignant transformation of oral leukoplakia (OLK) has emergingly gained momentum. In this short communication, we identified 5 retrospective follow-up studies and 5 cross-section comparative studies on this issue using formalin-fixed paraffin-embedded tissues. Copy number alteration (CNA) was demonstrated to increase with the grade of oral dysplasia. CNA-based algorithms showed better prediction performances than histological grade in assessing the risk of OLK malignant transformation. Importantly, we conducted a pooled-analysis on the mutation frequencies of the common oral cancer driver genes extracted from individual studies. The most common mutation gene was found to be TP53 (26.26 %; 95 % confidence intervals (CI), 20.61–32.82 %), followed by NOTCH1 (23.23 %; 95%CI, 17.87–29.61 %), FAT1 (16.67 %; 95%CI, 12.08–22.52 %), and CDKN2A (10.61 %; 95%CI, 6.98–15.73 %). Collectively, it is promising to establish molecular subtyping and risk stratification of OLK patients using genomic and mutational sequencing. We recommend the well-designed studies with a larger OLK patient population with clinical endpoints using fresh or frozen tissues and matched optimal samples as controls in further investigations.
Recommended Citation
Liu, Wei; Yuan, Jian; Zhu, Yuhan; Wang, Zirui; and Lv, Zhongjing
(2025)
"Evaluating the diagnostic value and prospects of genomic and mutational sequencing in malignant transformation of oral leukoplakia,"
Journal of Dental Sciences: Vol. 20:
Iss.
4, Article 8.
DOI: 10.1016/j.jds.2025.07.016
Available at:
https://jds.ads.org.tw/journal/vol20/iss4/8